SPOTLIGHT -
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
Weight Loss Industry Market Hit New High in 2023 Due to Weight Loss Drugs and Other Medical Interventions
The medical side of the market is growing while the commercial side seems to be struggling.
Normalizing Data with AI: Q&A with Andrew Anderson, VP of Innovation and Informatics Strategy at ACD/Labs
Anderson discusses how AI can be used to take data collected by different processes and bring it into a usable format.
Standard Industries Announces Challenge to Bring AI Into Molecular Synthesis
The winner will receive $1 million and the chance to partner with a major industry leader.
An Entire Flu Strain Was Seemingly Wiped Out During COVID-19 Pandemic
Researchers are debating whether to still include protection for this strain in vaccines.
Branding in the Digital Age: Q&A with Justin Chase, Executive Vice President of EVERSANA INTOUCH
Chases discusses how traditional media platforms still coexist with digital platforms and how this impacts promotion.
Bayer Won’t Be Splitting Up
The company plans to spend the coming years strengthening its market position and pipeline while also clearing its issues with litigation and debt.
Digital Tools and Rising Biopharma Manufacturing Costs: Q&A with Barry Heavey, Supply Chain Lead at Accenture
Heavey discusses how the industry can avoid having efforts to accelerate discovery and development be hampered by manufacturing concerns.
Bringing Neuroplastogens to the Window: Q&A With Delix CEO Mark Rus
Rus discusses his company’s work with neuroplastogens and how they differ from similar, psychedelic treatments.
WebMD Ignite Announces Collaboration with FDB
The partnership has the goal of improving patient education and treatment directions.
Neuropathy Action Foundation Releases White Paper On Adjusting Policies for Gene Therapies
The paper discusses multiple steps the industry can take to ensure that patients have access to these treatments.
Redefining Commercial with Modern Data for Today’s Complex Therapies: Q&A with Peter Stark, Executive VP and General Manager of Veeva Compass
Stark discusses how the ways that data is reshaping commercial strategies.
The State of Obesity-Related Clinical Research: Q&A with Simon Bruce, Vice President, Internal Medicine, Drug Development Solutions, ICON
Simon discusses a recent survey ICON conducted with professionals in obesity-related clinical research.
CDC’s Advisory Committee Recommends Another Round of Covid-19 Shots for Seniors
The agency updated its recommendations after a vote by the ACIP advisory committee.
FDA and Workflow Services Detail First 100 Days of Data Collection Partnership
The agency teamed up with the software company to develop platforms and networks to collect de-identified data.
Reese Pharmaceutical Announces At-Home Colon Cancer Screening Test
The device can detect potential warning signs of serious conditions.
NY AG Requests FDA Review Safety Labeling on Singulair
The medication already has a black box warning on it, but the AG’s office believes stricter actions should be taken.
Asthma Medication Xolair May Reduce Peanut Allergies, New Study Finds
FDA has approved the medication in adults and children with allergies.
Amgen Opens Its Most Advanced Manufacturing Facility in Ohio
The site will have a staff of 400 employees.
FDA Warns Against Using Smartwatches or Smart Rings to Measure Blood Glucose Levels
The agency issued a statement reminding the public that it has not approved any such devices for this use.
HLTH Inc. and GE Healthcare Reveal Healthcare-Themed Art Gallery
The gallery will be a part of the HLTH Europe event and will be open to all attendees.
Daniel O’Day Named Chair of PhRMA Board
The Gilead Sciences CEO will be joined by new board members from Pfizer and Sanofi.
Digital Biomarkers and Alzheimer’s Research: Q&A With Liam Kaufman, VP of Clinical Sciences at Cambridge Cognition
Kaufman discusses the ways the digital biomarkers are improving Alzheimer’s research by directly tackling some of the unique challenges that researchers face.
Emergent BioSolutions Names Joseph C. Papa As CEO
Papa will take over the over effective immediately.
AbbVie’s CEO Announces Retirement, To Be Succeeded by Robert A. Michael
The previous CEO, Richard A. Gonzalez, has served as CEO since 2013.
Planning for the World: Q&A With Sandra Anderson, SVP of International Commercialization at Cencora
Anderson discusses the complexities of planning for a global launch and the common mistakes companies make that cause problems along the way.
Will The Return of Mergers and Acquisitions Continue? Q&A With Arthur Wong, Managing Director, Healthcare, S&P Global Ratings
Wong discusses trends regarding M&A and how he expects this to continue and change in the coming months.
The Business Plan for Psychedelics: Q&A With Ben Lightburn, CEO of Filament Health
Lightburn discusses his company’s work with psychedelics and the unique business strategies required for these treatments.
Digging Deeper Into Bayer’s ASCO GU Presentation
Iris Kuss, head of clinical development, and Jorge Ortiz, head of medical affairs, discuss the company’s recent presentation at ASCO GU.
GSK Completes Acquisition of Aiolos Bio
This acquisition will add asthma treatment A1O-001 to GSK’s portfolio.
Quantum Computing Poised to Take Off in the Pharma Setting
Its path and application could model the same road as AI.